Lp(a), a unique form of bad cholesterol, is gaining attention for its role in cardiovascular disease. First described in 1963, recent advancements have improved our understanding of its implications for heart health. It is genetically determined and shows a strong association with increased risks of heart attacks and strokes, making measurement critical for personalized cardiovascular risk assessments. Unlike other cholesterol types, Lp(a) levels are largely unaffected by diet or medication, underscoring the need for genetic testing in assessing heart disease risk.
Measuring Lp(a) can help identify someone who should be paying more attention to their cardiovascular risks, leveraging personal genetics for better health assessments.
The levels of Lp(a) are about 90% determined by genetics alone, showcasing that lifestyle changes typically do not impact these levels.
Collection
[
|
...
]